Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Schmid-Kubista: Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related.... (0.12 sec) 

Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related …


KE Schmid-Kubista, I Krebs, B Gruenberger, F … - British Medical …, 2009 - bjo.bmj.com
Methods: Subjects with fibrovascular pigment epithelial detachment, subfoveal choroidal
neovascularisation extending under the geometric centre of the foveal avascular zone and/or macular
thickness of at least 300 µm in ...
Related articles - All 7 versions

Intravitreal bevacizumab (Avastin) for the treatment of choroidal neovascularization …

- prsjournal.com [PDF] 
KC Madhusudhana, SR Hannan, CPR Williams, SV … - British Medical …, 2007 - bjo.bmj.com
J Lotery, AJ Luff and RSB Newsom KC Madhusudhana, SR Hannan, CPR Williams, SV Goverdhan, C Rennie, A
... 118 cases age-related macular degeneration: results from treatment of choroidal
neovascularization in Intravitreal ...
Cited by 6 - Related articles - All 5 versions

Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular …


A Lux, H Llacer, F Heussen, AM Joussen - British Journal of …, 2007 - bjo.bmj.com
Methods: Forty-three patients with visual loss due to neovascular age-related macular disease (ARMD)
(44 eyes) underwent intravitreal injections of 1.25 mg (0.05 ml) bevacizumab and were followed up
every 4 weeks for 2, 3 or 6 months. ...
Cited by 10 - Related articles - BL Direct - All 3 versions

[CITATION] Ranibizumab therapy for neovascular age related macular degeneration


S Michels, PJ Rosenfeld - Retinal Physician, 2004
Cited by 10 - Related articles

Visual prognosis of second eyes in patients with unilateral late exudative age- …


D Pauleikhoff, M Radermacher, G Spital, C Müller, … - Graefe's Archive for …, 2002 - Springer
Abstract Purpose: A prospective longitudinal study was initiated to analyze the correlation between
the prognosis for the second eyes of patients with unilateral late exuda- tive AMD and the disease
pheno- type. Methods: Of the187 ...
Cited by 13 - Related articles - BL Direct - All 3 versions

Reading ability and central visual field after photodynamic therapy


I Krebs, S Binder, U Stolba, S Brunner - Ophthalmologica, 2004 - content.karger.com
Purpose: We examined whether photodynamic therapy (PDT) can prevent severe loss of reading acuity
and further depression of the visual field in cases of predominantly classic subfoveal
neovascularization due to ...
Cited by 14 - Related articles - BL Direct - All 5 versions

Visual improvement following intravitreal bevacizumab (Avastin) in exudative age- …


P YOGANATHAN, VA DERAMO, JC LAI, RK … - Retina, 2006 - journals.lww.com
Skip Navigation Links Home > November/December 2006 - Volume 26 - Issue 9 > Visual Improvement
Following Intravitreal Bevacizumab (Avast... ... From the *Department of Ophthalmology, North
Shore-Long Island Jewish Health ...
Cited by 75 - Related articles - BL Direct - All 2 versions

Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal …

- prsjournal.com [PDF] 
E Chen, CH PARK - Retina, 2006 - journals.lww.com
Retinal neovascularization rarely occurs in association with choroidal hemangioma.1 Shields et al2
studied the clinical manifestations of 200 consecutive cases of circumscribed choroidal hemangioma
and observed a choroidal ...
Cited by 67 - Related articles - BL Direct - All 4 versions

The Pros and Cons of Bevacizumab Therapy for Subfoveal Choroidal …


JI Lim, EOLT Options - Medscape Ophthalmology, 2005 - medscape.com
The number and variety of treatment options for choroidal neovascularization (CNV) due to
age-related macular degeneration (AMD) have grown tremendously in the last several years as retinal
physicians and basic scientists ...
Cited by 2 - Related articles - All 3 versions

Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular …


SJ Lee, JJ Lee, SY Kim, SD Kim - Korean Journal of …, 2009 - pubmedcentral.nih.gov
We report a case of ocular ischemic syndrome accompanied by neovascular glaucoma that was
successfully treated with Bevacizumab. A 70-year-old male patient diagnosed with neovascular
glaucoma of the left eye 3-4 years ...
Cited by 1 - Related articles - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google